These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2503263)
1. Impact of acute phase on concentrations of tissue plasminogen activator and plasminogen activator inhibitor in plasma after deep-vein thrombosis or open-heart surgery. Jansson JH; Norberg B; Nilsson TK Clin Chem; 1989 Jul; 35(7):1544-5. PubMed ID: 2503263 [No Abstract] [Full Text] [Related]
2. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis. Paramo JA; de Boer A; Colucci M; Jonker JJ; Collen D Thromb Haemost; 1985 Oct; 54(3):725. PubMed ID: 3937271 [No Abstract] [Full Text] [Related]
3. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis. Páramo JA; Alfaro MJ; Rocha E Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269 [TBL] [Abstract][Full Text] [Related]
4. Deficient tissue plasminogen activator release and normal tissue plasminogen activator inhibitor in a patient with recurrent deep vein thrombosis. Latham B; Kafoy EA; Barrett O; Gonzalez MF Am J Med; 1990 Feb; 88(2):199-200. PubMed ID: 2105644 [No Abstract] [Full Text] [Related]
5. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Jørgensen M; Bonnevie-Nielsen V Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670 [TBL] [Abstract][Full Text] [Related]
6. Relevance of free tPA assay following venous occlusion in patients with venous thromboembolic disease. Alessi MC; Juhan-Vague I; Valadier J; Philip Joet C; Holvoet P; Collen D Thromb Haemost; 1988 Apr; 59(2):346-7. PubMed ID: 3133817 [No Abstract] [Full Text] [Related]
10. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses]. Hach-Wunderle V; Scharrer I Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122 [TBL] [Abstract][Full Text] [Related]
11. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039 [TBL] [Abstract][Full Text] [Related]
12. Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation. Virji MA; Aggarwal S; Kang Y Transplant Proc; 1989 Jun; 21(3):3540-1. PubMed ID: 2500760 [No Abstract] [Full Text] [Related]
13. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391 [TBL] [Abstract][Full Text] [Related]
15. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Nilsson IM; Ljungnér H; Tengborn L Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531 [TBL] [Abstract][Full Text] [Related]
16. The role of the fibrinolytic system in thrombotic disease. Wiman B Acta Med Scand Suppl; 1987; 715():169-71. PubMed ID: 3109214 [No Abstract] [Full Text] [Related]
17. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722 [TBL] [Abstract][Full Text] [Related]
18. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI). Gram J; Kluft C; Jespersen J Thromb Haemost; 1987 Oct; 58(3):817-21. PubMed ID: 2448888 [TBL] [Abstract][Full Text] [Related]
19. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044 [TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator. Korninger C; Wagner O; Binder BR J Lab Clin Med; 1985 Jun; 105(6):718-24. PubMed ID: 3923146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]